Consolidated Statements of Income

in Million Yen or %, Japan GAAP 2019/03 2020/03 2021/03 2022/03
Net Sales 101,520 87,927 97,105 133,277
Costs of goods sold 60,430 53,452 60,190 79,772
Gross Profit on Sales 41,090 34,474 36,914 53,504
Selling, general and administrative expenses 20,869 22,192 21,351 24,954
Operating Profit 20,221 12,282 15,562 28,550
(Operating Profit Margin) 19.9% 14.0% 16.0% 21.4%
Non-operating income 688 255 540 994
Non-operating expenses 104 177 235 154
Recurring Profit 20,805 12,360 15,867 29,390
(Recurring Profit Margin) 20.5% 14.1% 16.3% 22.1%
Extraordinary gains 58 57 1,354 390
Extraordinary losses 419 1,712 1,074 34
Pre-tax Profit 20443 10,705 16,147 29,746
Total income tax and others 5,719 3,598 3,978 8,247
Net Profit before minority interests 14,724 7,106 12,169 21,499
(Net Profit Margin) 14.5% 8.1% 12.5% 16.1%
Net Profit attributable to minority interests 58 -49 -6 57
Net Profit attributable to owners of the parent 14,665 7,156 12,175 21,441

Consolidated Balance Sheet

in Million Yen or %, Japan GAAP 2019/03 2020/03 2021/03 2022/03
ASSETS
 Current Assets 110,094 97,771 111,516 133,785
 Fixed Assets 47,478 48,777 50,039 56,403
 Total Assets 157,573 146,549 161,556 190,188
LIABILITIES
 Current Liabilities 40,948 29,017 39,296 55,641
 Fixed Liabilities 9,220 7,857 5,482 3,561
 Total Liabilities 50,169 36,874 44,778 59,202
NET ASSETS
 Shareholder’s Equity 104,280 107,334 113,487 126,762
 Accumulated other comprehensive income 1,751 1,022 1,881 2,698
 Others 1,361 1,317 1,408 1,524
 Total Net Assets 107,403 109,674 116,777 130,986
Total Liabilities and Net Assets 157,573 146,549 161,556 190,188
(Equity Ratio) 67.3% 73.9% 71.4% 68.1%
(Return on Equity) 14.4% 6.7% 10.9% 17.5%

Consolidated Statements of Cash Flows

in Million Yen or %, Japan GAAP 2019/03 2020/03 2021/03 2022/03
From Operating Activities 12,932 5,965 22,062 24,062
From Investing Activities -13,952 -6,116 -5,191 -9,036
From Financing Activities 5,443 -6,375 -8,282 -10,350

R&D, Capex and Depreciation

in Million Yen 2019/03 2020/03 2021/03 2022/03
R&D Expenditure 7,500 8,234 7,193 8,146
Capital Expenditure 13,900 7,477 5,950 9,816
Depreciation and Amortization 2,655 3,450 3,516 3,574
Amortization of Goodwill 226 41 28 30